Amoxicillin Pulsys: Completed Phase III enrollment

AVNC completed enrollment of 620 patients in a 2-arm, non-inferiority, double-blind, North American Phase III trial. The trial is comparing 775 mg once-daily Amoxicillin Pulsys for 10 days to the stan...